+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gilead Sciences Inc - logo

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

From
From
From
Gallbladder Cancer Therapeutics Market 2024-2028 - Product Thumbnail Image

Gallbladder Cancer Therapeutics Market 2024-2028

  • Report
  • December 2023
  • 166 Pages
  • Global
From
Remdesivir Market Report 2025 - Product Thumbnail Image

Remdesivir Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
Immunotherapy Drugs Market 2024-2028 - Product Thumbnail Image

Immunotherapy Drugs Market 2024-2028

  • Report
  • November 2023
  • 163 Pages
  • Global
From
From
Invasive Fungal Infections Market Report 2025 - Product Thumbnail Image

Invasive Fungal Infections Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Diphtheria Market Report 2025 - Product Thumbnail Image

Diphtheria Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Aspergillosis Treatment Market Report 2025 - Product Thumbnail Image

Aspergillosis Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Long-Acting Insulin Analogue Market - Global Forecast to 2030 - Product Thumbnail Image

Long-Acting Insulin Analogue Market - Global Forecast to 2030

  • Report
  • August 2025
  • 186 Pages
  • Global
From
From
From
Systemic Aspergillosis and Systemic Candidiasis Market Report 2025 - Product Thumbnail Image

Systemic Aspergillosis and Systemic Candidiasis Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Loading Indicator